Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

BACKGROUND AND AIMS: Safety and efficacy of budesonide multimatrix, an oral extended-release second-generation corticosteroid designed for targeted delivery throughout the colon, were examined for induction of remission in patients with mild to moderate ulcerative colitis refractory to baseline mesa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, David T., Cohen, Russell D., Sandborn, William J., Lichtenstein, Gary R., Axler, Jeffrey, Riddell, Robert H., Zhu, Cindy, Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881669/
https://www.ncbi.nlm.nih.gov/pubmed/28333362
http://dx.doi.org/10.1093/ecco-jcc/jjx032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881669/
https://www.ncbi.nlm.nih.gov/pubmed/28333362
http://dx.doi.org/10.1093/ecco-jcc/jjx032

Ejemplares similares